U.S. government officials are launching a new study testing three drugs to tamp down an overactive response by the immune system that can cause severe illness or death in people with COVID-19.
The top U.S. infectious disease expert said AstraZeneca’s suspension of final testing of its COVID-19 vaccine candidate shows “one of the safety valves” built into the studies to spot any potential problems.
Health and Human Services Secretary Mark Ghaly said in an online briefing that the current system was not designed to handle the work that came with the outbreak in California.
The Food and Drug Administration on Wednesday authorized the first rapid coronavirus test that doesn’t need any special computer equipment to get results.
Potential accuracy issues with a widely used coronavirus test could lead to false results for patients, U.S. health officials warned.
With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away.
The pandemic is showing the problems created by a hodgepodge of public health systems that relies on private laboratories.
The world’s biggest COVID-19 vaccine study got underway Monday with the first of 30,000 planned volunteers helping to test shots created by the U.S. government.
The Trump administration will pay Pfizer nearly $2 billion for a December delivery of 100 million doses of a COVID-19 vaccine the pharmaceutical company is developing.
Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot.